Structural studies on HLA-G: Implications for ligand and receptor binding

被引:51
作者
Clements, Craig S. [1 ]
Kjer-Nielsen, Lars
McCluskey, James
Rossjohn, Jamie
机构
[1] Monash Univ, Sch Biomed Sci, Dept Biochem & Mol Biol, Prot Crystallog Unit, Clayton, Vic 3800, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia
基金
澳大利亚研究理事会; 英国医学研究理事会;
关键词
HLA-G; class Ib; NK receptors; x-ray crystallography;
D O I
10.1016/j.humimm.2006.09.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human leukocyte antigen-G (HLA-G) is a class Ib major histocompatibility complex (MHC) molecule that is specifically expressed in immune-privileged tissues. The overall structure of HLA-G resembles other class I MHC molecules, in which a heavy chain comprised of three domains is noncovalently associated with ss(2)microglobulin (ss(2)m). A nine-residue self-peptide is bound within a cleft formed by two alpha-helices and a ss-sheet floor. An extensive network of contacts is formed between the peptide and the binding cleft, leading to a constrained mode of binding reminiscent of that observed in HLA-E. The alpha 3 domain of HLA-G, the putative binding site for leukocyte immunoglobulinlike receptor-1 (LIR-1) and -2, is structurally distinct from class Ia MHC molecules, providing a basis for the observed differences in affinity for these ligands. In addition, a disulfide-bonded dimer adopts an oblique conformation, providing the possibility of a 1:2 (HLA-G dimer:receptor) complex stoichiometry. The relative orientation of the HLA-G protomers in the dimer structure suggests that it is unlikely that dimerization is involved in killer immunoglobulinlike receptor 2DL4 (KIR2DL4) binding.
引用
收藏
页码:220 / 226
页数:7
相关论文
共 35 条
[1]   Tetrameric complexes of human histocompatibility leukocyte antigen (HLA)-G bind to peripheral blood myelomonocytic cells [J].
Allan, DSJ ;
Colonna, M ;
Lanier, LL ;
Churakova, TD ;
Abrams, JS ;
Ellis, SA ;
McMichael, AJ ;
Braud, VM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (07) :1149-1155
[2]   Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand [J].
Boyington, JC ;
Motyka, SA ;
Schuck, P ;
Brooks, AG ;
Sun, PD .
NATURE, 2000, 405 (6786) :537-543
[3]   Disulfide bond-mediated dimerization of HLA-G on the cell surface [J].
Boyson, JE ;
Erskine, R ;
Whitman, MC ;
Chiu, M ;
Lau, JM ;
Koopman, LA ;
Valter, MM ;
Angelisova, P ;
Horejsi, V ;
Strominger, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (25) :16180-16185
[4]   The LILR family: modulators of innate and adaptive immune pathways in health and disease [J].
Brown, D ;
Trowsdale, J ;
Allen, R .
TISSUE ANTIGENS, 2004, 64 (03) :215-225
[5]   The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18 [J].
Chapman, TL ;
Heikema, AP ;
Bjorkman, PJ .
IMMUNITY, 1999, 11 (05) :603-613
[6]   The production, purification and crystallization of a soluble form of the nonclassical MHC HLA-G: the essential role of cobalt [J].
Clements, CS ;
Kjer-Nielsen, L ;
Kostenko, L ;
McCluskey, J ;
Rossjohn, J .
ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2006, 62 :70-73
[7]   Crystal structure of HLA-G: A nonclassical MHC class I molecule expressed at the fetal-maternal interface [J].
Clements, CS ;
Kjer-Nielsen, L ;
Kostenko, L ;
Hoare, HL ;
Dunstone, MA ;
Moses, E ;
Freed, K ;
Brooks, AG ;
Rossjohn, J ;
McCluskey, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (09) :3360-3365
[8]   Nonclassical HLA-G molecules are classical peptide presenters [J].
Diehl, M ;
Munz, C ;
Keilholz, W ;
Stevanovic, S ;
Holmes, N ;
Loke, YW ;
Rammensee, HG .
CURRENT BIOLOGY, 1996, 6 (03) :305-314
[9]   Crystal structure of the human natural killer cell inhibitory receptor KIR2DLI-HLA-Cw4 complex [J].
Fan, QR ;
Long, EO ;
Wiley, DC .
NATURE IMMUNOLOGY, 2001, 2 (05) :452-460
[10]   Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8αα [J].
Gao, GF ;
Willcox, BE ;
Wyer, JR ;
Boulter, JM ;
O'Callaghan, CA ;
Maenaka, K ;
Stuart, DI ;
Jones, EY ;
Van Der Merwe, PA ;
Bell, JI ;
Jakobsen, BK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15232-15238